You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 7, 2024

LISINOPRIL AND HYDROCHLOROTHIAZIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Lisinopril And Hydrochlorothiazide patents expire, and what generic alternatives are available?

Lisinopril And Hydrochlorothiazide is a drug marketed by Aurobindo, Chartwell Rx, Corepharma, Epic Pharma Llc, Hikma Intl Pharms, Invagen Pharms, Lupin, Norvium Bioscience, Prinston Inc, Sandoz, Sun Pharm Inds Ltd, Teva, and Watson Labs. and is included in thirteen NDAs.

The generic ingredient in LISINOPRIL AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; lisinopril. There are thirty-two drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; lisinopril profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for LISINOPRIL AND HYDROCHLOROTHIAZIDE?
  • What are the global sales for LISINOPRIL AND HYDROCHLOROTHIAZIDE?
  • What is Average Wholesale Price for LISINOPRIL AND HYDROCHLOROTHIAZIDE?
Summary for LISINOPRIL AND HYDROCHLOROTHIAZIDE
Drug patent expirations by year for LISINOPRIL AND HYDROCHLOROTHIAZIDE
Recent Clinical Trials for LISINOPRIL AND HYDROCHLOROTHIAZIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
The University of Texas Health Science Center, HoustonPhase 4
IPCA Laboratories Ltd.Phase 1
Scripps Translational Science InstituteN/A

See all LISINOPRIL AND HYDROCHLOROTHIAZIDE clinical trials

Pharmacology for LISINOPRIL AND HYDROCHLOROTHIAZIDE

US Patents and Regulatory Information for LISINOPRIL AND HYDROCHLOROTHIAZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Ltd LISINOPRIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 076007-002 Jul 1, 2002 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz LISINOPRIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 076262-001 Jul 1, 2002 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sun Pharm Inds Ltd LISINOPRIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 076007-003 Jul 1, 2002 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz LISINOPRIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 076262-002 Jul 1, 2002 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aurobindo LISINOPRIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 077606-001 Mar 14, 2006 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.